Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Expert Opinion on Biological Therapy|December 1, 2001
Interference with the urokinase plasminogen activator system: a promising therapy concept for solid tumoursB Muehlenweg, S Sperl, V Magdolen, et al.Journal of Molecular Biology|May 26, 1999
The solution structure and dynamics of human neutrophil gelatinase-associated lipocalinM Coles, T Diercks, B Muehlenweg, et al.Methods in Molecular Medicine|February 23, 2011
RFLP Molecular Analysis of the Urokinase-Type Plasminogen Activator GeneB Muehlenweg, A Schnelzer, B Türkmen, et al.British Journal of Cancer|January 24, 2007
Inhibition of urokinase plasminogen activator with a novel enzyme inhibitor, WXC-340, ameliorates endotoxin and surgery-accelerated growth of murine metastasesS D Killeen, E J Andrews, J H Wang, et al.The Journal of Biological Chemistry|July 27, 2000
A novel type of bifunctional inhibitor directed against proteolytic activity and receptor/ligand interaction. Cystatin with a urokinase receptor binding siteB Muehlenweg, I Assfalg-Machleidt, S G Parrado, et al.Thrombosis Research|March 9, 2000
Epitope mapping of monoclonal antibodies directed to PAI-1 using PAI-1/PAI-2 chimera and PAI-1-derived synthetic peptidesB Muehlenweg, E Guthaus, N A de Prada, et al.Pageof 1